Contact
Please use this form to send email to PR contact of this press release:
Proteostasis Therapeutics Announces Progression of PTI-428 and PTI-801 to Longer Duration Studies in CF Subjects
TO:
Please use this form to send email to PR contact of this press release:
Proteostasis Therapeutics Announces Progression of PTI-428 and PTI-801 to Longer Duration Studies in CF Subjects
TO: